Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review.

ABSTRACT: Background Corticosteroid therapy for the treatment of clinically manifest cardiac sarcoidosis is generally recommended. Our group previously systematically reviewed the data in 2013; since then, there has been increasing quality and quantity of data and also interest in nonsteroid agents. Methods and Results Studies were identified from MEDLINE, EMBASE, Cochrane Controlled Trials Register, Cochrane Database of Systematic Reviews, and the National Institutes of Health ClinicalTrials.gov database. The quality of included articles was rated using Scottish Intercollegiate Guidelines Network 50. Outcomes examined were atrioventricular conduction, left ventricular function, ventricular arrhythmias, and mortality. A total of 3527 references were retrieved, and 34 publications met the inclusion c

SUBMITTER: Fazelpour S 

PROVIDER: S-EPMC8649244 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature